Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Dehydrocrenatidine |
Trade Name | |
Synonyms | |
Drug Descriptions |
Dehydrocrenatidine is a selective JAK2 inhibitor, which decreases STAT3 signaling to prevent cell proliferation (PMID: 25583084). |
DrugClasses | JAK2 Inhibitor 16 |
CAS Registry Number | 65236-62-6 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Dehydrocrenatidine | Dehydrocrenatidine | 0 | 0 |